NCT03193944View on ClinicalTrials.gov

Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran

PHASE2CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

February 10, 2017

Primary Completion Date

May 10, 2017

Study Completion Date

July 10, 2017

Conditions

Vitamin D DeficiencyDiabetes MellitusHypertensionLipid Metabolism DisordersObesity, Abdominal

Interventions

DRUG

D-vitin, soft gelatin capsule (vitamin D3,50000 IU)

Intervention group: The respondents in intervention group will receive 50000 vitamin D for 8 weeks. Plus, brochures and pamphlets related to nutrition and health.

DRUG

Placebo vitamin D3

vitamin D as a placebo

Trial Locations (1)

Unknown

Maryam Zarei, Karaj

All Listed Sponsors

collaborator

Universiti Putra Malaysia

OTHER

lead

Alborz Medical University

OTHER_GOV

NCT03193944 - Vitamin D Supplementation on Metabolic Syndrome Indicators Among Older Adults, Alborz Province, Iran | Biotech Hunter | Biotech Hunter